Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Comparative Studies on the Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies

Ambar Farooqui, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Cassie Bacher, Jeanine Walenga, PhD, Ahmed Kouta, Walter Jeske, PhD, Bruce Lewis, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 2446.

https://doi.org/10.1182/blood-2019-131825

Published: 2019

Journal Articles

Immune Mediated Cytopenia's Following Cord Blood Transplantation for Hurler's Syndrome: A Failure of Pre-Transplant Immune Suppression

David Deambrosis, MBBS, FRACP, Ryan Hum, Prashant Hiwarkar, Kay Poulton, Denise Bonney, Helen Jane Campbell, FRCP, MD FRCPath, Robert Wynn, MD

Blood (2018) 132 (Supplement 1): 3374.

https://doi.org/10.1182/blood-2018-99-112995

Published: 2018

Journal Articles

Membrane Remodeling By Pathogenic Antibodies Underlies Monocyte Activation in Heparin-Induced Thrombocytopenia

Izabella Andrianova, Vincent M Hayes, BS, Daria Madeeva, MD, Rustem I. Litvinov, PhD, Douglas B. Cines, MD, Mortimer Poncz, MD, John W. Weisel, PhD, Lubica Rauova, MD PhD

Blood (2015) 126 (23): 2244.

https://doi.org/10.1182/blood.V126.23.2244.2244

Published: 2015

Journal Articles

Excess Heparan Sulphate Inhibits CXCL12-Mediated Hematopoietic Cell Migration and Engraftment After Bone Marrow Transplant in Mice with Mucopolysaccharidosis Type I,

H. Angharad Watson, PhD, Rebecca J Holley, PhD, Kia J Langford-Smith, Fiona L Wilkinson, PhD, Toin H van Kuppevelt, Robert Wynn, MD, J. Ed Wraith, Catherine L R Merry, Brian W Bigger, PhD

Blood (2011) 118 (21): 4010.

https://doi.org/10.1182/blood.V118.21.4010.4010

Published: 2011

Journal Articles

Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants

Jawed Fareed, PhD, Cafer Adiguzel, MD, Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Bruce E Lewis, MD, Harry L. Messmore, Jr., MD, Vinod Bansal, MD

Blood (2011) 118 (21): 4326.

https://doi.org/10.1182/blood.V118.21.4326.4326

Published: 2011

Journal Articles

Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants

Jawed Fareed, PhD, Rakesh Wahi, MD, Indermohan Thethi, MD, Debra Hoppensteadt, Ph.D., Vinod Bansal, MD, Jeanine M. Walenga, PhD, Harry L. Messmore, MD

Blood (2011) 118 (21): 4322.

https://doi.org/10.1182/blood.V118.21.4322.4322

Published: 2011

Journal Articles

Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II

Matthew Ndonwi, Oname O. Burlingame, Aaron S. Miller, Douglas M. Tollefsen, George J. Broze, Jr, Daniel E. Goldberg

Blood (2011) 117 (23): 6347–6354.

https://doi.org/10.1182/blood-2010-12-326876

Published: 2011

Includes: Supplemental data

Journal Articles

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Jawed Fareed, Melanie Clark, Vinod Bansal, Lauren Myers, Omer Iqbal, MD, Debra Hoppensteadt, Eduardo Ramacciotti, M.D., Ph.D., Jeanine M. Walenga, PhD

Blood (2009) 114 (22): 1069.

https://doi.org/10.1182/blood.V114.22.1069.1069

Published: 2009

Journal Articles

Oversulfated Chondroitin Sulfate Is Not the Sole Contaminant in Recalled Heparin Preparations.

Jawed Fareed, Eduardo Ramacciotti, Debra Hoppensteadt, Nasir Sadeghi, Arif Hussain, David VanThiel, Magdalena George

Blood (2009) 114 (22): 1070.

https://doi.org/10.1182/blood.V114.22.1070.1070

Published: 2009

Journal Articles

Higher Prevalence of Heparin-Induced Thrombocytopenia Antibodies in Asian Indian Population: Is This Due to Contaminated Heparin?

Meganathan Kannan, PhD, Firdaus Ahmad, Renu Saxena, MD, Jawed Fareed

Blood (2009) 114 (22): 4182.

https://doi.org/10.1182/blood.V114.22.4182.4182

Published: 2009

Journal Articles

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Jawed Fareed, Ph.D., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Cafer Adiguzel, MD, Omer Iqbal, MD, Jeanine M. Walenga, PhD

Blood (2008) 112 (11): 4048.

https://doi.org/10.1182/blood.V112.11.4048.4048

Published: 2008

Journal Articles

Heparin Cofactor II (HCII) Levels and the Risk of Ischemic Stroke. No Deleterious Role of HCII Deficiency but Potential Protective Role of High Plasma Level

Pierre A. Toulon, Mathieu Zuber, Raphael Adda, Jean-Louis Mas

Blood (2008) 112 (11): 5344.

https://doi.org/10.1182/blood.V112.11.5344.5344

Published: 2008

Journal Articles

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Li He, Tusar K. Giri, Cristina P. Vicente, Douglas M. Tollefsen

Blood (2008) 111 (8): 4118–4125.

https://doi.org/10.1182/blood-2007-12-127928

Published: 2008

Journal Articles

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Cristina P. Vicente, Li He, Douglas M. Tollefsen

Blood (2007) 110 (13): 4261–4267.

https://doi.org/10.1182/blood-2007-04-086611

Published: 2007

Journal Articles

Immobilized Glycosaminoglycans Reduce Thrombopoietin-Induced Apoptosis during In Vitro Expansion of Megakaryocyte Precursors from Cord Blood CD34+ Cells.

Vipuil Kishore, James F. Eliason, PhD, Howard W.T. Matthew, PhD

Blood (2006) 108 (11): 1127.

https://doi.org/10.1182/blood.V108.11.1127.1127

Published: 2006

Journal Articles

The Effects of Glycosaminoglycans on Thrombopoietin-Induced Megakaryocytopoiesis.

Kenji Takahashi, PhD, Ikuo Kashiwakura, PhD, Tsutomu Toki, PhD, Keiichi Takagaki, PhD

Blood (2006) 108 (11): 4219.

https://doi.org/10.1182/blood.V108.11.4219.4219

Published: 2006

Journal Articles

Heparin and Endogenous Heparan Sulfate Modulate Bone Morphogenetic Protein-4 (BMP-4) Signaling and Activity.

Shaukat A. Khan, PhD, Matthew S. Nelson, BS, Chendong Pan, MS, MD, Patrick M. Gaffney, MD, Pankaj Gupta, MD

Blood (2006) 108 (11): 4230.

https://doi.org/10.1182/blood.V108.11.4230.4230

Published: 2006

Journal Articles

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II

Tusar K. Giri, Douglas M. Tollefsen

Blood (2006) 107 (7): 2753–2758.

https://doi.org/10.1182/blood-2005-09-3755

Published: 2006

Journal Articles

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Cristina P. Vicente, Li He, Mauro S. G. Pavão, Douglas M. Tollefsen

Blood (2004) 104 (13): 3965–3970.

https://doi.org/10.1182/blood-2004-02-0598

Published: 2004

Journal Articles

Role of Thrombin Exosites in Protection from Inhibition by Antithrombin in the Presence of Heparin and Fibrin.

James C. Fredenburgh, PhD, Alan R. Stafford, MSc, Jeffrey I. Weitz, MD

Blood (2004) 104 (11): 1721.

https://doi.org/10.1182/blood.V104.11.1721.1721

Published: 2004

NARROW

Comparative Studies on the Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies

Immune Mediated Cytopenia's Following Cord Blood Transplantation for Hurler's Syndrome: A Failure of Pre-Transplant Immune Suppression

Membrane Remodeling By Pathogenic Antibodies Underlies Monocyte Activation in Heparin-Induced Thrombocytopenia

Excess Heparan Sulphate Inhibits CXCL12-Mediated Hematopoietic Cell Migration and Engraftment After Bone Marrow Transplant in Mice with Mucopolysaccharidosis Type I,

Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants

Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants

Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Oversulfated Chondroitin Sulfate Is Not the Sole Contaminant in Recalled Heparin Preparations.

Higher Prevalence of Heparin-Induced Thrombocytopenia Antibodies in Asian Indian Population: Is This Due to Contaminated Heparin?

Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions

Heparin Cofactor II (HCII) Levels and the Risk of Ischemic Stroke. No Deleterious Role of HCII Deficiency but Potential Protective Role of High Plasma Level

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Immobilized Glycosaminoglycans Reduce Thrombopoietin-Induced Apoptosis during In Vitro Expansion of Megakaryocyte Precursors from Cord Blood CD34+ Cells.

The Effects of Glycosaminoglycans on Thrombopoietin-Induced Megakaryocytopoiesis.

Heparin and Endogenous Heparan Sulfate Modulate Bone Morphogenetic Protein-4 (BMP-4) Signaling and Activity.

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Role of Thrombin Exosites in Protection from Inhibition by Antithrombin in the Presence of Heparin and Fibrin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only